The latest market intelligence study Global Cardiac Catheterization Market report Analysis relies on the statistics derived from both primary and secondary research
Market Research Future (MRFR)’s study has found out that the global cardiac implants market is expected to scale a CAGR of 7.82% CAGR during the forecast period 2018 to 2023. The study further reveals that the market is prognosticated to reach a valuation of USD 38,054.3 Mn by the close of 2023.
The increasing occurrences of Cardiovascular Diseases (CVDs)have revolutionized the revenue model of the healthcare sector. The Centers for Disease Control and Prevention (CDC) has underlined in its report, which was published in 2017, that 2.7 to 6.1 million people in the U.S. alone suffered from atrial fibrillation, a common form of heart arrhythmia. People are getting increasingly aware of the risks associated with heart diseases which has led to a drastic increase in healthcare expenditure. A similar trend is expected to be exhibited in the years to come, thus, catapulting the cardiac implants market on an upward trajectory.
Cardiac implants enable the monitoring and maintenance of normal functions of the heart and are expected to be in excessive demand over the next couple of years. The rising elderly population has unleashed growth opportunities to the cardiac implants market as cardiovascular diseases are more prevalent among them. It has been observed that the heart and blood vessels become stiff due to aging which is the root cause of increasing CVDs among the older people. It can lead to heart failure, coronary artery disease, atrial fibrillation, etc. which is expected to motivate the growth trajectory of the market over the assessment period.
Key players are focusing on the introduction of innovative implants for addressing the rising need for effective heart treatments. Technological innovations are presumed to dictate the growth pattern of the cardiac implants market in the foreseeable future. Also, the market is likely to witness the inflow of investments for research & development activities. Case to the point is, Israeli scientists have developed fully personalized tissue implants for heart, brain and spinal cord from the patient’s stomach cells which won’t be rejected by the body. However, the high cost of implants is anticipated to check market growth in the forthcoming years.
Key Players:
The prominent players operating in the cardiac implants market are –
- Abbott (US)
- Edwards Lifesciences Corporation (US)
- Amg International (Germany)
- B. Braun Melsungen AG (Germany)
- Boston Scientific Corporation (US)
- Biotronik (US)
- LivaNova PLC (UK)
- SynCardia Systems, Inc. (Arizona)
- Medtronic Plc (US)
- Terumo Corporation (Japan)
Market Segmentation:
This MRFR report presents a detailed segmental analysis of the global cardiac implants market based on device, indication, and end-user. Based on device, the market has been segmented into implantable loop recorder/implantable cardiac monitor, cardiac rhythm management devices, prosthetic heart valve devices, coronary stents, ventricular assist devices, and others.
By indication, the market has been segmented into arrhythmias, myocardial ischemia, acute myocardial infarction, heart failure, and others.
The cardiac implants market, by end-user, has been segmented into hospitals, cardiac care centers, ambulatory centers & home care, academic institutes, and others.
Americas Expected to Exhibit Positive Growth
The geographical assessment of the global Cardiac Implants Market spans across four major regions — Americas, Europe, Asia Pacific, and the Middle East and Africa (MEA). Americas is expected to strike a healthy growth rate owing to the large-scale adoption of cardiac implantable electronic devices in North America. The region is also observing an increase in the patient population which is prognosticated to aid the proliferation of the market. Europe is forecasted to demonstrate similar growth trends in the foreseeable future.
Browse the market data and information spread across 163 pages with 196 data tables and 21 figures of the report “Cardiac Implants Market- Forecast 2018–2023” in-depth alongside table of content (TOC) at: https://www.marketresearchfuture.com/reports/cardiac-implants-market-6726
Asia Pacific signifies strong growth potential and is poised to expand at a relatively higher CAGR through the projection period. The boom witnessed in the medical tourism of the region is one of the key factors expected to contribute towards the expansion of the cardiac implants market during the forecast period. On the contrary, the Middle East & Africa holds the least share of the market and is anticipated to signify restricted growth in the forthcoming years.
Latest Industry News:
Medtronic plc, the world’s largest medical device company, is set to acquire EPIX Therapeutics, which is a designer of temperature-controlled, catheter-based cardiac ablation systems used for the treatment of cardiac arrhythmias. The move is aimed at the expansion of Medtronic’s cardiac ablation portfolio.
CorMatrix Cardiovascular, Inc., a medical device company, has announced the launch of the study of its Cor Tricuspid ECM cardiac valve designed for treating adults suffering from endocarditis as well as pediatric patients with congenital heart valve disease.
Browse Related Reports:
Robotic Flight Simulator Surgery Market
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.
They are used in the surgical procedures that have the ability to exchange oxygen and carbon dioxide while the patient is undergoing a surgical procedures.
This is mainly owing to less hemolysis, less blood trauma and less bleeding.
In 2019, hospital held the largest share in the oxygenator market.
This is mainly owing to the improved patient safety and awareness among patients about health.
During cardiac surgery, the work of heat and lungs can be replaced by using oxygenator machine which is driving the growth of oxygenator market.
Oxygenator top 10 companies are LivaNova PLC, Medtronic, EUROSETS, Chalice Medical Ltd, MAQUET Holding B.V. & Co.
The Global Implantable Cardiac Monitor Market held USD 521.41 million in 2019 and is predicted to reach USD 1,179.10 million by 2030 with a CAGR of 7.7% from 2020-2030.The implantable cardiac monitor is also known as the implantable loop recorder.
The implantable cardiac monitor technology eliminates the need for bulks external monitors that require wire leads attached to the patient.
This has boosted the implantable cardiac monitor market size.Access Full Description of this report at:- https://www.nextmsc.com/report/implantable-cardiac-monitor-market Top Companies: General Electric Company, Koninklijke Philips N.V., Abbott Laboratories, Biotronik SE & Co. KG, LivaNova PLC, Medtronic plc, Nihon Kohden Corporation, Boston Scientific Corporation, Edwards Lifescience Corporation, Phoenix Heart Center and others.The implantable cardiac monitor market is segmented on the basis of indication, end user, and geography.
On the basis of end user, the market covers hospitals, cardiac centers & clinics, ambulatory surgical centers.
Geographic breakdown and analysis of each of the aforesaid segments include regions comprising North America, Europe, Asia-Pacific, and RoW.Request free sample copy of this report at:- https://www.nextmsc.com/Implantable-Cardiac-Monitor-Market/request-sample North America denotes a higher adoption of the implantable cardiac monitor and is anticipated to hold the highest implantable cardiac monitor market share during the forecast period.
This is attributable to the factors including the high adoption rate of technologically advanced implantable cardiac monitors, the presence of major key healthcare companies, high consumer awareness, and favorable reimbursement framework.
This market report directs business in right direction by giving insights about products, market, customers, competitors and marketing strategy at right time.
This market report helps to develop a successful marketing strategy for your business.
Endoscopic Vessel Harvesting report is very helpful to all sizes of business which makes it simpler to take informed decisions in providing the different aspect of this industry.
The Global Endoscopic Vessel Harvesting market report contains all the company profiles of the major players and brands.Endoscopic vessel harvesting market is expected to gain market growth in the forecast period of 2020 to 2027.
Data Bridge Market Research analyses the market to account to USD 606.95 million by 2027 growing at a CAGR of 3.75% in the above-mentioned forecast period.
The growing global burden of cardiovascular diseases will help in driving the growth of the endoscopic vessel harvesting market in the forecast period of 2020-2027.A combination of best industry insight, practical solutions, talent solutions and latest technology has been used to structure this excellent Endoscopic Vessel Harvesting report.
What the market looks like?
To define, describe, and measure the global Patient Derived Xenograft (PDX) models market by model type, tumor type, application, end user, and region.
To analyze the opportunities in the global patient derived xenograft models market for key stakeholders and provide details of the competitive landscape for major market leaders.
To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific (APAC), and the Rest of the World.
Pre-Clinical Drug Development and Basic Cancer Research: The preclinical drug development and basic cancer research segment is expected to account for the largest share of the global PDX models market.
The large share of this segment can be mainly attributed to the increasing number of research activities in the field of oncology drug research.
The study includes an accurate estimate of the current industry scenario along with the market size, market volume, and revenue garnered by the industry.
The report delivers radical data about the competitive landscape of the Endoscopic Vessel Harvesting Devices industry and a thorough bifurcation of the regions where the Endoscopic Vessel Harvesting Devices market has established a significant footing.
The report studies the following companies in detail: Maquet Holding B.V. & Co.
The report offers key details about the production volume and price analysis.The report further provides key insights into the market share held by each product and application in the Endoscopic Vessel Harvesting Devices market.
The report also sheds light on the supply chains and the changes in the trends of the upstream raw materials and downstream distributors.The report explains the market share and sales volume of each company, along with the key details of the operations of these companies.
The report further offers extensive coverage of their product portfolio, business expansion plans, gross profit margins, revenue contribution, investment plans, and financial standings.
